Opioid and Benzodiazepine Coprescribing in the United States Before and After US Food and Drug Administration Boxed Warning

scientific article published on 18 September 2019

Opioid and Benzodiazepine Coprescribing in the United States Before and After US Food and Drug Administration Boxed Warning is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1001/JAMAPSYCHIATRY.2019.2563
P698PubMed publication ID31532463

P50authorMark OlfsonQ91346889
P2093author name stringMarissa King
Victoria Shu Zhang
P2860cites workBenzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort studyQ35716083
CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016.Q38778400
Trends in the Concomitant Prescribing of Opioids and Benzodiazepines, 2002-2014.Q39850246
Opioid Prescribing in the United States Before and After the Centers for Disease Control and Prevention's 2016 Opioid GuidelineQ64136510
P921main subjectboxed warningQ879952
P577publication date2019-09-18
P1433published inJAMA PsychiatryQ635830
P1476titleOpioid and Benzodiazepine Coprescribing in the United States Before and After US Food and Drug Administration Boxed Warning

Reverse relations

cites work (P2860)
Q99576454Benzodiazepine Use among Medicare, Commercially Insured, and Veteran Older Adults, 2013-2017
Q102379539FDALabel for drug repurposing studies and beyond

Search more.